Must-See 2023 Archive - Event Guides

TIDES CMC Tracks

Oligonucleotide Chemistry, Manufacturing & Controls (CMC) Track

Dive into the cutting edge of oligonucleotide development with our dedicated CMC track, where scientific innovation meets practical application.

What You’ll Learn

Accelerate development through optimized CMC strategies that reduce risk and improve timelines
Master next-generation analytical techniques and QC to ensure product consistency and quality
Streamline regulatory pathways to bring therapies to market faster and more efficiently
Scale manufacturing with confidence, supported by real-world case studies and expert insights

Featured Keynote Sessions

“I Love Conjugates”: The GalNAc Revolution and Its Impact on Oligonucleotide Therapeutic Development

Muthiah (Mano) Manoharan PhD
Senior Vice President of Drug Innovation and Distinguished Research Scientist at Alnylam Pharmaceuticals

Tuesday, 20 May 2025
9:00am – 9:45am
Harbor Ballroom (Level 2)

Clinical Update on Oligonucleotides for Cardiovascular Disease

Sam Tsimikas, MD
Senior Vice President of Global Cardiovascular Development at Ionis Pharmaceuticals

Tuesday, 20 May 2025
1:00pm – 1:45pm
Harbor Ballroom (Level 2)

Whether you’re advancing toward commercialization or refining early-stage processes, this track delivers the tools and knowledge you need to drive oligo success from lab to launch. Make sure to check out our exciting sessions in these tracks.

#tidesusa

TIDES Tracks

Oligonucleotide Discovery, Preclinical & Clinical Track

Explore the full journey from discovery to clinic in this forward-looking track designed to accelerate oligonucleotide therapeutics.

Gain insights

Design breakthrough drug-like properties that enhance stability, specificity, and efficacy
Fast-track candidate selection with smarter screening and predictive tools
Optimize clinical trial design to maximize success rates and minimize delays
Benchmark your strategies against the latest data and case studies from industry leaders

Featured Keynote Sessions

The Science Behind the GLP-1 Medicines: A Historic View and Future Outlook

Dr. Lotte Bjerre Knudsen, PhD
Chief Scientific Advisor & Head of GLP-1 CoE at Novo Nordisk A/S

Tuesday, 20 May 2025
8:15am – 9:00am
Harbor Ballroom (Level 2)

Antibody Oligonucleotide Conjugates (AOCs): RNA Delivery Beyond the Liver

Mike Flanagan, PhD
Chief Scientific Officer at Avidity Biosciences

Tuesday, 20 May 2025
1:45pm – 2:30pm
Harbor Ballroom (Level 2)

Whether you’re advancing your first candidate or refining a robust pipeline, this track empowers you to innovate with confidence and speed. Make sure to check out our exciting sessions in these tracks.

#tidesusa

TIDES Networking

TIDES USA Networking Opportunities

At TIDES USA, meaningful connections happen beyond the sessions. Explore networking events designed to inspire collaboration and community.

Networking Events

Poster Sessions

Engage with presenters and explore the latest research during our networking refreshment breaks every day in the Exhibit Hall.

Networking Receptions

Mix and mingle with peers over drinks and bites at the Grand Opening of Poster and Exhibit Hall and Networking Refreshment Break.

Mix and mingle with peers over drinks & bites at these receptions:

Grand Opening of the Poster & Exhibit Halls for the afternoon refreshment break – Tuesday, May 20th 2:30 – 3:30 pm
Opening Night Networking Cocktail Reception – Tuesday, May 20th 5:00 – 6:30 pm in level 1 Grand Exhibit Hall and level 2 Harbor Foyer Exhibit Hall
Second Night Networking Cocktail Reception – Wednesday, May 21st 5:45 – 6:45 pm in level 1 Grand Exhibit Hall and level 2 Harbor Foyer Exhibit Hall

Fun Run/Walk

Start your day with fresh air, fitness, and informal chats.

Wednesday, 21 May 2025
6:30am – 7:30am

Sunrise Yoga

Recharge with a relaxing session to energize body and mind. Yoga mats will be provided – Please do RESERVE your spot – space is limited!

Thursday, 22 May 2025
6:45am – 7:45am

Expand Your Network

Ask the Experts

Click here for our interactive floorplan to see where our sponsors will be during the event!

Be sure to check out our TIDES Talks!

Whether you’re making new contacts or catching up with colleagues, these experiences make networking easy and enjoyable.

#tidesusa

TIDES Pre-Conference Workshops

Pre-Conference Workshops

Kick off your TIDES USA experience with deep-dive workshops led by industry experts. Whether you’re new to the field or looking to sharpen your expertise, there’s a session for you.

Morning workshops run 9am to 12:30pm. Afternoon workshops run 1:30pm to 5:00pm. Click below for featured talks.

Morning Sessions:

Therapeutic Oligonucleotide Design & Delivery

Featuring Introduction to Therapeutic Oligonucleotides – Design, Function and Delivery with Mike Webb, Ph. D., Founder and CEO of Mike Webb Pharma.

Monday, 19 May 2025
9:00am – 10:20am in Mission Beach Level 3

Novel Manufacturing Paradigms & Regulatory Strategies

Featuring Evolution of Oligonucleotide Therapeutics: Impact on Manufacturing and CMC Strategy with James Powell, VP RNAi CMC, Boulder Site Head at Novo Nordisk.

Monday, 19 May 2025
9:10am – 9:45am in Hillcrest on Level 3

Genome Editing & Delivery

Featuring The History and Evolution of Genome Editing with Dr. John Zuris, PhD, Director of Delivery and Editing Technologies at Editas Medicine.

Monday, 19 May 2025
9:05am – 9:45am in Golden Hill Level 3

Translational Strategies for Peptides

Featuring Introduction to Fast Tracking to First in Humans and CMC Requirements and Considerations with Dave Garman, PhD, VP of Translation and Development at ProteinQure.

Monday, 19 May 2025
9:10am – 9:45am in Solana Beach Level 3

Afternoon Sessions:

AI & ML in Drug Design

Featuring Foundation Models: A New Hope for Emergent Drug Discovery Intelligence with Brendan Frey, PhD, Founder and Chief Innovation Officer at Deep Genomics.

Monday, 19 May 2025
1:35pm – 2:05pm in Golden Hill Level 3

Analytical Control Strategies for Oligonucleotides

Featuring Introduction to Analytical Control Strategies for Therapeutic Oligonucleotides with Mike Webb, Ph. D., Founder and CEO of Mike Webb Pharma.

Monday, 19 May 2025
1:30pm – 2:30pm in Mission Beach Level 3

Next-Gen QC in Oligo Analysis

Elucidating Guide RNA Purity and Impurities Through NGS and LC-MS(/MS) Technologies

Jan Nickolaus, Ph.D.,
Head of Quality Control, BioSpring GmbH, Germany

Monday, 19 May 2025
2:15pm – 2:45pm in Hillcrest Level 3

Sustainable Manufacturing & Green Chemistry

Breaking with Traditions: Supporting Next Generation Peptide and Oligonucleotide Drugs with Intensified Processes

Ralf Eisenhuth, Ph.D.,
Principal Scientist, Bachem AG, Switzerland

Monday, 19 May 2025
1:35pm – 2:10pm in Solana Beach Level 3

Get hands-on insights to accelerate innovation before the main event begins!